638 related articles for article (PubMed ID: 23859617)
1. Targeting SREBP-1-driven lipid metabolism to treat cancer.
Guo D; Bell EH; Mischel P; Chakravarti A
Curr Pharm Des; 2014; 20(15):2619-26. PubMed ID: 23859617
[TBL] [Abstract][Full Text] [Related]
2. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.
Guo D; Reinitz F; Youssef M; Hong C; Nathanson D; Akhavan D; Kuga D; Amzajerdi AN; Soto H; Zhu S; Babic I; Tanaka K; Dang J; Iwanami A; Gini B; Dejesus J; Lisiero DD; Huang TT; Prins RM; Wen PY; Robins HI; Prados MD; Deangelis LM; Mellinghoff IK; Mehta MP; James CD; Chakravarti A; Cloughesy TF; Tontonoz P; Mischel PS
Cancer Discov; 2011 Oct; 1(5):442-56. PubMed ID: 22059152
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.
Geng F; Cheng X; Wu X; Yoo JY; Cheng C; Guo JY; Mo X; Ru P; Hurwitz B; Kim SH; Otero J; Puduvalli V; Lefai E; Ma J; Nakano I; Horbinski C; Kaur B; Chakravarti A; Guo D
Clin Cancer Res; 2016 Nov; 22(21):5337-5348. PubMed ID: 27281560
[TBL] [Abstract][Full Text] [Related]
4. Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake.
Haskins JW; Zhang S; Means RE; Kelleher JK; Cline GW; Canfrán-Duque A; Suárez Y; Stern DF
Sci Signal; 2015 Nov; 8(401):ra111. PubMed ID: 26535009
[TBL] [Abstract][Full Text] [Related]
5. TNF-α increases lipogenesis via JNK and PI3K/Akt pathways in SZ95 human sebocytes.
Choi JJ; Park MY; Lee HJ; Yoon DY; Lim Y; Hyun JW; Zouboulis CC; Jin M
J Dermatol Sci; 2012 Mar; 65(3):179-88. PubMed ID: 22305016
[TBL] [Abstract][Full Text] [Related]
6. Visfatin-induced upregulation of lipogenesis via EGFR/AKT/GSK3β pathway promotes breast cancer cell growth.
Rajput PK; Varghese JF; Srivastava AK; Kumar U; Yadav UCS
Cell Signal; 2023 Jul; 107():110686. PubMed ID: 37084841
[TBL] [Abstract][Full Text] [Related]
7. Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen.
Yamauchi Y; Furukawa K; Hamamura K; Furukawa K
Cancer Res; 2011 Jul; 71(14):4989-97. PubMed ID: 21632551
[TBL] [Abstract][Full Text] [Related]
8. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
Yang YA; Han WF; Morin PJ; Chrest FJ; Pizer ES
Exp Cell Res; 2002 Sep; 279(1):80-90. PubMed ID: 12213216
[TBL] [Abstract][Full Text] [Related]
9. Lipid metabolism reprogramming and its potential targets in cancer.
Cheng C; Geng F; Cheng X; Guo D
Cancer Commun (Lond); 2018 May; 38(1):27. PubMed ID: 29784041
[TBL] [Abstract][Full Text] [Related]
10. Polydatin Improves Glucose and Lipid Metabolisms in Insulin-Resistant HepG2 Cells through the AMPK Pathway.
Hao J; Huang K; Chen C; Liang Y; Wang Y; Zhang X; Huang H
Biol Pharm Bull; 2018; 41(6):891-898. PubMed ID: 29863077
[TBL] [Abstract][Full Text] [Related]
11. The Akt-SREBP nexus: cell signaling meets lipid metabolism.
Krycer JR; Sharpe LJ; Luu W; Brown AJ
Trends Endocrinol Metab; 2010 May; 21(5):268-76. PubMed ID: 20117946
[TBL] [Abstract][Full Text] [Related]
12. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP.
Porstmann T; Griffiths B; Chung YL; Delpuech O; Griffiths JR; Downward J; Schulze A
Oncogene; 2005 Sep; 24(43):6465-81. PubMed ID: 16007182
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
[TBL] [Abstract][Full Text] [Related]
14. 25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway.
Ma Y; Xu L; Rodriguez-Agudo D; Li X; Heuman DM; Hylemon PB; Pandak WM; Ren S
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1369-79. PubMed ID: 18854425
[TBL] [Abstract][Full Text] [Related]
15. Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt signaling pathway.
Hao J; Chen C; Huang K; Huang J; Li J; Liu P; Huang H
Eur J Pharmacol; 2014 Dec; 745():152-65. PubMed ID: 25310908
[TBL] [Abstract][Full Text] [Related]
16. PI3K/Akt pathway mediates high glucose-induced lipogenesis and extracellular matrix accumulation in HKC cells through regulation of SREBP-1 and TGF-β1.
Hao J; Liu S; Zhao S; Liu Q; Lv X; Chen H; Niu Y; Duan H
Histochem Cell Biol; 2011 Feb; 135(2):173-81. PubMed ID: 21240525
[TBL] [Abstract][Full Text] [Related]
17. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
[TBL] [Abstract][Full Text] [Related]
18. EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.
Guo D; Prins RM; Dang J; Kuga D; Iwanami A; Soto H; Lin KY; Huang TT; Akhavan D; Hock MB; Zhu S; Kofman AA; Bensinger SJ; Yong WH; Vinters HV; Horvath S; Watson AD; Kuhn JG; Robins HI; Mehta MP; Wen PY; DeAngelis LM; Prados MD; Mellinghoff IK; Cloughesy TF; Mischel PS
Sci Signal; 2009 Dec; 2(101):ra82. PubMed ID: 20009104
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Chi X; Qu N; Wang C
Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
[TBL] [Abstract][Full Text] [Related]
20. Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth.
Cheng C; Ru P; Geng F; Liu J; Yoo JY; Wu X; Cheng X; Euthine V; Hu P; Guo JY; Lefai E; Kaur B; Nohturfft A; Ma J; Chakravarti A; Guo D
Cancer Cell; 2015 Nov; 28(5):569-581. PubMed ID: 26555173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
